Healthcare products company CCA Industries Inc (OTC:CAWW) disclosed on Monday that its income amounted to USD349,320 for the second quarter ended 31 May 2019.
This marks an improvement when compared with a loss of USD292,320 for the same period in fiscal 2018.
Revenues of USD5.458m were generated for the three months ended 31 May 2019,up over revenues of USD4.225m for the comparable period in fiscal 2018.
EBITDA of USD574,176 were recorded for the second quarter ended 31 May 2019, a rise from EBITDA of USD231,136 for the corresponding period in fiscal 2018.
Mylan collaborates with Gilead Sciences for remdesivir distribution
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
Verato Launches Verato Enrich to Accelerate COVID-19 Response
Lannett Company reports third quarter fiscal 2020 financial results
Eli Lilly and Company's board approves USD0.74 per share dividend for Q2 2020
Eli Lilly announces Q2 dividend
Bio-Rad Receives FDA Emergency Use Authorization for Droplet Digital PCR SARS-CoV-2 Test Kit
Bio-Rad's SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization